(Q34578135)

3 August 2017

1 reference

title

Emerging therapies in the long-term management of hyperuricaemia and gout (English)

1 reference

3 August 2017

Stamp LK

1

1 reference

3 August 2017

O'Donnell JL

series ordinal

2

1 reference

3 August 2017

Chapman PT

series ordinal

3

1 reference

3 August 2017

publication date

1 April 2007

1 reference

Internal Medicine Journal

3 August 2017

published in

1 reference

3 August 2017

volume

37

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

258-266

1 reference

A literature review of the epidemiology and treatment of acute gout

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Recent advances in the management of gout and hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Alcohol intake and risk of incident gout in men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Purine-rich foods, dairy and protein intake, and the risk of gout in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01315.X

10.1111/J.1445-5994.2007.01315.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference